Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.28 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 2 Parkinson's papers of 113 | 0.85 |
| pathways Reactome | 5 pathways; mostly vesicle traffic | 1.00 |
No case: the score is under the bar. Receipt 1403
Sealed predictions
- ARPC2 in dopamine neurons, braak+0.25 (p 0.520) → -0.15 (p 0.697)receipt 1410
Swarm cases
receipt 1410: ARPC2 in dopamine neurons, braak
- power
- full sample -0.11 (p 0.677, n 18), 95% CI -0.55 to +0.38. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.00 (p 0.997, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.07 (p 0.794, n 18). could be the mix.
- skeptic
- leave-one-out range -0.25 to +0.00, sign flips 1; without severely affected donors -0.11 (p 0.677, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ARPC2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts